Send to a Friend Font Size: Increase Decrease

Carl Icahn

Carl Icahn's Portfolio

Ticker	# of Shares	Price	Value
IEP	79,238,262	$35.70	$2,828,805,954
MSI	38,292,235	$46.40	$1,776,759,704
EP	65,983,829	$25.79	$1,701,722,950
MMI	33,505,706	$38.65	$1,294,995,537
FDML	75,980,915	$14.21	$1,079,688,803
CLX	12,039,196	$65.50	$788,567,338
FRX	26,083,088	$29.75	$775,971,868
CLX	7,098,678	$65.50	$464,963,409
CLX	6,587,378	$65.50	$431,473,259
HAIN	7,130,563	$37.99	$270,890,089
View Additional Portfolio Information »

http://www.icahnreport.com/

Carl Icahn is a billionaire financier, ranking #18 on the 2007 Forbes 400 list with an estimated net worth of $14.5 billion.

Icahn built a name for himself in the 1980s as a corporate raider. After keeping quite for years, Icahn made a major comeback as a 'activist investor'. An activist investor agitates companies for changes, including buyouts, share buybacks, and dividend increases.

Icahn has successfully pushed for changes at Time Warner (NYSE: TWX) and Temple-Inland (NYSE: TIN), among others. Icahn won board seats at Motorola (NYSE: MOT) after first failing.

In 2007, Icahn's activism successfully pushed biotech company MedImmune into a sales agreement with AstraZeneca (NYSE: AZN). Icahn is also involved with biotech company Imclone Systems (Nasdaq: IMCL), where he is Chairman of the Board.

In early, 2008 Icahn activist target BEA Systems (Nasdaq: BEAS) was sold to Oracle (Nasdaq: ORCL). Icahn held a 13% stake in BEA.

Icahn is also involved with developments at Biogen Idec (Nasdaq: BIIB) and WCI Communities (NYSE: WCI), which both unsuccessfully explored sales. WCI rejected a $22 per share takeover offer from Icahn in early 2007, only to see its stock plummet on the housing slowdown.

In 2008, Icahn targeted Yahoo! (Nasdaq: YHOO) after the Internet company failed to work out an acceptable merger agreement with Microsoft (Nasdaq: MSFT) Microsoft walked away from its bid for Yahoo! after months of bickering.

Login to help us fill in information about this entity.

Form 4 HAIN CELESTIAL GROUP For: Nov 18 Filed by: ICAHN BRETT Nov 22, 2011 05:35PM

Carl Icahn Files Q3 13F Nov 14, 2011 05:55PM

Carl Icahn Liquidates Biogen Idec (BIIB), Chesapeake Energy (CHK); Targets Oshkosh (OSK), Forest Labs (FRX) and Commercial Metals (CMC) Aug 15, 2011 06:24PM

Hain Celestial (HAIN) Has the Right Gluten-Free Ingredients for Gains - Cramer May 27, 2011 09:27AM

Icahn's Icahn Capital Shows New Stake in Amgen (AMGN), Clorox (CLX) and Southern Union (NYSE: SUG); Raises Dynegy (DYN), Lowers Chesapeake (CHK) May 16, 2011 04:57PM

Jan 11, 2011 05:31PM Icahn Adds More to Hain Celestial Stake
Nov 15, 2010 05:39PM Icahn Hangs on to Pharmas, Makes Housing Play, Increases Lions Gate Holding in Recent 13F (MOT, MAS, HAIN, More...)
Aug 16, 2010 11:33AM Carl Icahn Shows New Stakes In Energy Names and a Gun Maker (APC, NRG, SWHC)
Jul 7, 2010 04:05PM Hain Celestial (HAIN) and Carl Icahn Reach Agreement; Brett Icahn and David Schechter Appointed to Board
May 14, 2010 10:49AM Icahn Goes Organic (HAIN)
May 13, 2010 05:57PM After-Hours Movers 5/13: BSMD, EFOI, HAIN, BIDZ Higher; BBI, XRM, COSI, CA, QTM Lower
May 13, 2010 05:47PM Icahn Reports 11.92% Stake in The Hain Celestial Group (HAIN)
Nov 4, 2009 02:42PM Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)

Carl Icahn

Carl Icahn's Portfolio

Free News Feed